Erika H. James
Known title: DirectorCIK: 0001753124
Associated companies
Transaction History
| MS | ▲ Buy | Grant | 1,310 | $0 | 6/1/2026 | View on chart |
| MS | ▼ Sell | Gift | 522 | $0 | 1/16/2026 | View on chart |
| MS | ▲ Buy | Grant | 2,155 | $0 | 6/1/2025 | View on chart |
| MS | ▲ Buy | Grant | 2,675 | $0 | 6/1/2024 | View on chart |
| MS | ▲ Buy | Grant | 3,168 | $0 | 6/1/2023 | View on chart |
| MS | ▲ Buy | Grant | 2,945 | $0 | 6/1/2022 | View on chart |
| MS | ▲ Buy | Grant | 806 | $0 | 2/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Morgan Stanley Q3 earnings met but stock remains under pressure
Morgan Stanley reported strong third-quarter results, yet the stock has not shown a significant reaction. The firm also highlighted stable demand in aerospace and defense and issued a positive signal regarding SpaceX. These developments provide fundamental support, even as the stock trades near its 52-week low and faces technical resistance.
Morgan Stanley Q3 earnings met but stock remains under pressure. Morgan Stanley reported strong third-quarter results, yet the stock has not shown a significant reaction. The firm also highlighted stable demand in aerospace and defense and issued a positive signal regarding SpaceX. These developments provide fundamental support, even as the stock trades near its 52-week low and faces technical resistance.